How long does tirzepatide stay in your system? It has a half-life of about 5 days, so it stays in your body for roughly 25 to 30 days (about a month) after your last dose.[1][2] That is the time for about five half-lives to pass, after which very little drug remains. The long half-life is why Mounjaro and Zepbound are injected only once a week.
How long the drug lingers matters for birth control, surgery, pregnancy plans and what to expect if you stop. For background, see our tirzepatide profile.
Tirzepatide half-life and clearance
| Measure | Value |
|---|---|
| Time to peak level after an injection | About 24 hours (range 8 to 72)[1] |
| Time to steady level with weekly dosing | About 4 weeks[1] |
| Elimination half-life | About 5 to 6 days[1][2] |
| Mostly cleared (about 5 half-lives) | Roughly 25 to 30 days |
| Bioavailability after injection | About 80%[1] |
Tirzepatide lasts so long because it carries a fatty acid chain that binds to albumin, a protein in the blood, which slows its removal.[1] The body breaks it down into smaller pieces, and those pieces leave through urine and stool. Intact tirzepatide is not found in urine or stool.[1]
A rough guide to how much is left after a single dose, assuming a 5-day half-life:
- 5 days: about half
- 10 days: about a quarter
- 15 days: about an eighth
- 25 to 30 days: under 5%
Kidney function does not change how tirzepatide is cleared, and age, sex, race and body weight have no meaningful effect on it either.[1]
What happens after you stop
Because levels fall gradually, the effects of tirzepatide also fade over several weeks rather than overnight. People often notice appetite returning in the weeks after a last dose.
The weight effect fades over months. In SURMOUNT-4, people switched to placebo after 36 weeks of tirzepatide regained an average of 14% of their body weight over the following year.[5] For options after reaching a goal weight, see the tirzepatide maintenance dose.
If you miss a dose, the labels allow you to take it within 4 days. After that, skip it and resume on your usual day.[1][2]
Birth control pills: the 4-week rule
Tirzepatide slows stomach emptying, which can reduce how well oral medicines are absorbed. This effect is largest after the first dose and becomes smaller over time.[1][3]
Both labels give the same advice for oral hormonal contraceptives:[1][2]
- Switch to a non-oral method, or add a barrier method such as condoms.
- Do this for 4 weeks after starting tirzepatide.
- Do it again for 4 weeks after each dose increase.
- Non-oral hormonal methods such as implants, hormonal IUDs, patches, rings or injections are not expected to be affected.
A 2024 review found that tirzepatide was the only drug in its class with trial data showing lower absorption of an oral contraceptive. Other GLP-1 drugs did not show a significant effect.[4]
Surgery and anesthesia
Tirzepatide’s effect on the stomach is relevant before procedures that use general anesthesia or deep sedation.
- The warning: there have been rare reports of pulmonary aspiration (inhaling stomach contents into the lungs) in people on GLP-1 drugs who still had food in the stomach despite fasting as instructed.[1][2]
- What the labels say: there is not enough data to say whether changing fasting instructions or pausing tirzepatide lowers this risk.[1][2]
- What to do: tell your surgeon and anesthesia team that you take tirzepatide, well before the procedure date.[1]
Because tirzepatide takes about a month to clear, pausing a single dose does not remove it from your body. Decisions about holding doses before surgery should come from the team doing the procedure. Our guide to GLP-1 drugs before surgery covers this in more detail.
Pregnancy and breastfeeding
- Zepbound: weight loss offers no benefit during pregnancy and may harm the fetus. The label says to stop Zepbound once pregnancy is recognized.[1]
- Mounjaro: there is not enough human data to judge the risk. The label says it should be used during pregnancy only if the benefit justifies the potential risk to the fetus.[2]
- Planning a pregnancy: neither label gives a specific number of weeks to stop before trying to conceive.[1][2] Given the roughly one-month clearance time, plan the timing with your prescriber.
- Pregnancy registry: Lilly runs a registry for people exposed to Zepbound during pregnancy (1-844-524-0039).[1]
- Breastfeeding: in a small study, tirzepatide in breast milk was undetectable or low, with the last measurable levels 5 days after a dose. Effects on a breastfed baby are unknown.[1]
Switching to or from another GLP-1 drug
Because tirzepatide lingers for weeks, timing matters when changing medicines.
- Do not overlap. The Zepbound label says not to use it together with other tirzepatide products or any GLP-1 receptor agonist, such as semaglutide.[1]
- There is no official conversion. Neither the Mounjaro nor the Zepbound label gives a dose conversion to or from another GLP-1 drug.[1][2] When to give the first dose of the new drug, and at what strength, is a decision for your prescriber.
- Expect some carry-over. For a week or two after the last tirzepatide dose, a meaningful amount is still in the body, so side effects from the new drug can stack with the tail of the old one.
For semaglutide’s own clearance time, see our semaglutide profile.
Overdose and side effects that linger
If someone takes too much tirzepatide, the labels advise supportive care and observation that takes the roughly 5-day half-life into account.[1][2] In practice, side effects such as nausea after a dose increase can last several days because the drug stays in the body.
For how quickly effects start, see how long does tirzepatide take to work. For timing doses around trips, see traveling with GLP-1 medications.
